| Literature DB >> 34446261 |
Matthew J Page1, Joanne E McKenzie2, Patrick M Bossuyt3, Isabelle Boutron4, Tammy C Hoffmann5, Cynthia D Mulrow6, Larissa Shamseer7, Jennifer M Tetzlaff8, Elie A Akl9, Sue E Brennan2, Roger Chou10, Julie Glanville11, Jeremy M Grimshaw12, Asbjørn Hróbjartsson13, Manoj M Lalu14, Tianjing Li15, Elizabeth W Loder16, Evan Mayo-Wilson17, Steve McDonald2, Luke A McGuinness18, Lesley A Stewart19, James Thomas20, Andrea C Tricco21, Vivian A Welch22, Penny Whiting18, David Moher23.
Abstract
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. Full English text available from:www.revespcardiol.org/en.Entities:
Keywords: Escritura médica; Guía de publicación; Medical writing; Meta-analysis; Metanálisis; Publishing guide; Revisión sistemática; Systematic review
Mesh：
Year: 2021 PMID： 34446261 DOI： 10.1016/j.rec.2021.07.010
Source DB: PubMed Journal: Rev Esp Cardiol (Engl Ed) ISSN： 1885-5857